Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.

Verbeek J, Lannoo M, Pirinen E, Ryu D, Spincemaille P, Vander Elst I, Windmolders P, Thevissen K, Cammue BP, van Pelt J, Fransis S, Van Eyken P, Ceuterick-De Groote C, Van Veldhoven PP, Bedossa P, Nevens F, Auwerx J, Cassiman D.

Gut. 2014 Jun 10. pii: gutjnl-2014-306748. doi: 10.1136/gutjnl-2014-306748. [Epub ahead of print]

PMID:
24917551
[PubMed - as supplied by publisher]
2.

Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.

Serviddio G, Bellanti F, Tamborra R, Rollo T, Capitanio N, Romano AD, Sastre J, Vendemiale G, Altomare E.

Gut. 2008 Jul;57(7):957-65. doi: 10.1136/gut.2007.147496. Epub 2008 Feb 28.

PMID:
18308829
[PubMed - indexed for MEDLINE]
3.

Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.

Larter CZ, Yeh MM, Haigh WG, Van Rooyen DM, Brooling J, Heydet D, Nolan CJ, Teoh NC, Farrell GC.

Obesity (Silver Spring). 2013 Jun;21(6):1189-99. doi: 10.1002/oby.20123. Epub 2013 May 10.

PMID:
23666886
[PubMed - indexed for MEDLINE]
4.

Etiopathogenesis of nonalcoholic steatohepatitis.

Chitturi S, Farrell GC.

Semin Liver Dis. 2001;21(1):27-41. Review.

PMID:
11296694
[PubMed - indexed for MEDLINE]
5.

Roux-en-Y gastric bypass improves hepatic mitochondrial function in obese rats.

Peng Y, Murr MM.

Surg Obes Relat Dis. 2013 May-Jun;9(3):429-35. doi: 10.1016/j.soard.2011.06.012. Epub 2011 Jul 6.

PMID:
21890425
[PubMed - indexed for MEDLINE]
6.

L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.

Ishikawa H, Takaki A, Tsuzaki R, Yasunaka T, Koike K, Shimomura Y, Seki H, Matsushita H, Miyake Y, Ikeda F, Shiraha H, Nouso K, Yamamoto K.

PLoS One. 2014 Jul 1;9(7):e100627. doi: 10.1371/journal.pone.0100627. eCollection 2014.

PMID:
24983359
[PubMed - in process]
Free PMC Article
7.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
[PubMed - indexed for MEDLINE]
8.

Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model.

Serviddio G, Bellanti F, Tamborra R, Rollo T, Romano AD, Giudetti AM, Capitanio N, Petrella A, Vendemiale G, Altomare E.

Eur J Clin Invest. 2008 Apr;38(4):245-52. doi: 10.1111/j.1365-2362.2008.01936.x.

PMID:
18339004
[PubMed - indexed for MEDLINE]
9.

The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.

Cong WN, Tao RY, Tian JY, Liu GT, Ye F.

Life Sci. 2008 May 7;82(19-20):983-90. doi: 10.1016/j.lfs.2008.01.022. Epub 2008 Mar 4.

PMID:
18417155
[PubMed - indexed for MEDLINE]
10.

Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.

Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, de Vos R, Roskams T, Trautwein C.

Gut. 2008 May;57(5):655-63. doi: 10.1136/gut.2007.134288.

PMID:
18408102
[PubMed - indexed for MEDLINE]
11.

A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.

Yimin, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H.

Lab Invest. 2012 Feb;92(2):265-81. doi: 10.1038/labinvest.2011.159. Epub 2011 Nov 7.

PMID:
22064320
[PubMed - indexed for MEDLINE]
Free Article
12.

Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.

Depner CM, Philbrick KA, Jump DB.

J Nutr. 2013 Mar;143(3):315-23. doi: 10.3945/jn.112.171322. Epub 2013 Jan 9.

PMID:
23303872
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance.

Nakamura A, Tajima K, Zolzaya K, Sato K, Inoue R, Yoneda M, Fujita K, Nozaki Y, Kubota KC, Haga H, Kubota N, Nagashima Y, Nakajima A, Maeda S, Kadowaki T, Terauchi Y.

Diabetologia. 2012 Dec;55(12):3382-91. doi: 10.1007/s00125-012-2703-1. Epub 2012 Sep 7.

PMID:
22955994
[PubMed - indexed for MEDLINE]
14.

Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression.

Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, Bateman AC, Clough GF, Poston L, Hanson MA, McConnell JM, Byrne CD.

Hepatology. 2009 Dec;50(6):1796-808. doi: 10.1002/hep.23205.

PMID:
19816994
[PubMed - indexed for MEDLINE]
15.

A mouse model for nonalcoholic steatohepatitis.

Sundaresan S, Vijayagopal P, Mills N, Imrhan V, Prasad C.

J Nutr Biochem. 2011 Oct;22(10):979-84. doi: 10.1016/j.jnutbio.2010.08.011. Epub 2010 Dec 28.

PMID:
21190824
[PubMed - indexed for MEDLINE]
16.

Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.

Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN.

Hepatology. 2013 Jan;57(1):81-92. doi: 10.1002/hep.25789.

PMID:
22508243
[PubMed - indexed for MEDLINE]
17.

Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha.

Ramirez-Tortosa MC, Ramirez-Tortosa CL, Mesa MD, Granados S, Gil A, Quiles JL.

Free Radic Biol Med. 2009 Oct 1;47(7):924-31. doi: 10.1016/j.freeradbiomed.2009.06.015. Epub 2009 Jun 17.

PMID:
19539747
[PubMed - indexed for MEDLINE]
18.

Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.

Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.

J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.

PMID:
21929649
[PubMed - indexed for MEDLINE]
19.

A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.

Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F.

Clin Exp Pharmacol Physiol. 2013 Jul;40(7):422-30. doi: 10.1111/1440-1681.12102.

PMID:
23611112
[PubMed - indexed for MEDLINE]
20.

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

Begriche K, Igoudjil A, Pessayre D, Fromenty B.

Mitochondrion. 2006 Feb;6(1):1-28. Epub 2006 Jan 5. Review.

PMID:
16406828
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk